| Dr Anjeli Krishnan Isaac, MD | |
|
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
| (425) 502-3000 | |
| Not Available |
| Full Name | Dr Anjeli Krishnan Isaac |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 11511 Ne 10th St, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184880767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 036.115981 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Greek and Spanish-speaking patients with kidney or ureteral stones can now read EAU Patient Information in their native language. The Endourology, Laparoscopy and Urotechnology Section of the Hellenic Urologic Association (HUA) has provided the Greek translation and the Spanish translation is the result of a collaboration between the Spanish Association of Urology (AEU) and the Dominican Republic Society of Urology (SDU).
We all have them - positive memories of personal events that are a delight to recall, and painful recollections that we would rather forget. A new study reveals that what we do with our emotional memories and how they affect us has a lot to do with our gender, personality and the methods we use (often without awareness) to regulate our feelings.
The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.
Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke Conference in New Orleans on February 2, offer hope to many of these patients.
› Verified 7 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Greek and Spanish-speaking patients with kidney or ureteral stones can now read EAU Patient Information in their native language. The Endourology, Laparoscopy and Urotechnology Section of the Hellenic Urologic Association (HUA) has provided the Greek translation and the Spanish translation is the result of a collaboration between the Spanish Association of Urology (AEU) and the Dominican Republic Society of Urology (SDU).
We all have them - positive memories of personal events that are a delight to recall, and painful recollections that we would rather forget. A new study reveals that what we do with our emotional memories and how they affect us has a lot to do with our gender, personality and the methods we use (often without awareness) to regulate our feelings.
The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.
Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke Conference in New Orleans on February 2, offer hope to many of these patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anjeli Krishnan Isaac, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 | Dr Anjeli Krishnan Isaac, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 |
News Archive
Greek and Spanish-speaking patients with kidney or ureteral stones can now read EAU Patient Information in their native language. The Endourology, Laparoscopy and Urotechnology Section of the Hellenic Urologic Association (HUA) has provided the Greek translation and the Spanish translation is the result of a collaboration between the Spanish Association of Urology (AEU) and the Dominican Republic Society of Urology (SDU).
We all have them - positive memories of personal events that are a delight to recall, and painful recollections that we would rather forget. A new study reveals that what we do with our emotional memories and how they affect us has a lot to do with our gender, personality and the methods we use (often without awareness) to regulate our feelings.
The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.
Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke Conference in New Orleans on February 2, offer hope to many of these patients.
› Verified 7 days ago
Julie S Francis, MD Dermatology Medicare: Medicare Enrolled Practice Location: 14030 Ne 24th St, Suite 202, Bellevue, WA 98007 Phone: 425-454-1104 Fax: 425-454-1290 | |
Samir P. Master, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1414 116th Ave Ne Ste E, Bellevue, WA 98004 Phone: 425-753-2918 | |
Keith Cameron Carlson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Andy J Chien, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 | |
Dr. John P. Hackett, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1605 116th Ave Ne, Ste 102, Bellevue, WA 98004 Phone: 425-456-0709 Fax: 425-456-0358 | |
Dr. James Philip Harnisch, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1600 116th Ave Ne, #306, Bellevue, WA 98004 Phone: 425-455-5111 Fax: 425-455-5113 |